Role of Circulating Angiotensin Converting Enzyme 2 in Left Ventricular Remodeling following Myocardial Infarction: A Prospective Controlled Study

PLoS ONE

Volumn 8, Issue 4, 2013, Pages

  Ortiz Pérez, José T ^a   Riera, Marta ^b   Bosch, Xavier ^a   De Caralt, Teresa M ^c   Perea, Rosario J ^c   Pascual, Julio ^b   Soler, María José ^b  

^a UNIVERSITY OF BARCELONA   (Spain)

^b INST MUNIC D INVESTIGACIO MEDICA   (Spain)

^c HOSPITAL CLÍNIC   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN CONVERTING ENZYME 2; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; TUMOR NECROSIS FACTOR ALPHA CONVERTING ENZYME;

ADULT; ARTICLE; CARDIOVASCULAR MAGNETIC RESONANCE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME BLOOD LEVEL; FEMALE; FLUORESCENCE ANALYSIS; HEART INFARCTION SIZE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART LEFT VENTRICLE FAILURE; HUMAN; MAJOR CLINICAL STUDY; MALE; MOLECULAR PATHOLOGY; PROSPECTIVE STUDY; PROTEIN FUNCTION; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; TISSUE REPAIR;

AGED; CASE-CONTROL STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; MYOCARDIAL INFARCTION; MYOCARDIUM; PEPTIDYL-DIPEPTIDASE A; PROSPECTIVE STUDIES; RISK FACTORS; STROKE VOLUME; VENTRICULAR REMODELING;

EID: 84876432226     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0061695     Document Type: Article

References (23)

1. Pfeffer MA, McMurray JJ, Velazquez EJ, Rouleau JL, Kober L, et al. (2003) Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both. N Engl J Med 349: 1893-1906.
2. Pitt B, Remme W, Zannad F, Neaton J, Martinez F, et al. (2003) Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med 348: 1309-1321.
3. Wu E, Ortiz JT, Tejedor P, Lee DC, Bucciarelli-Ducci C, et al. (2008) Infarct size by contrast enhanced cardiac magnetic resonance is a stronger predictor of outcomes than left ventricular ejection fraction or end-systolic volume index: prospective cohort study. Heart 94: 730-736.
4. Loot AE, Roks AJ, Henning RH, Tio RA, Suurmeijer AJ, et al. (2002) Angiotensin-(1-7) attenuates the development of heart failure after myocardial infarction in rats. Circulation 105: 1548-1550.
5. Crackower MA, Sarao R, Oudit GY, Yagil C, Kozieradzki I, et al. (2002) Angiotensin-converting enzyme 2 is an essential regulator of heart function. Nature 417: 822-828.
6. Zhong JC, Huang DY, Yang YM, Li YF, Liu GF, et al. (2004) Upregulation of angiotensin-converting enzyme 2 by all-trans retinoic acid in spontaneously hypertensive rats. Hypertension 44: 907-912.
7. Epelman S, Tang WH, Chen SY, Van Lente F, Francis GS, et al. (2008) Detection of soluble angiotensin-converting enzyme 2 in heart failure: insights into the endogenous counter-regulatory pathway of the renin-angiotensin-aldosterone system. J Am Coll Cardiol 52: 750-754.
8. Burrell LM, Risvanis J, Kubota E, Dean RG, MacDonald PS, et al. (2005) Myocardial infarction increases ACE2 expression in rat and humans. Eur Heart J 26: 369-375.
9. Goulter AB, Goddard MJ, Allen JC, Clark KL, (2004) ACE2 gene expression is up-regulated in the human failing heart. BMC Med 2: 19.
10. Vickers C, Hales P, Kaushik V, Dick L, Gavin J, et al. (2002) Hydrolysis of biological peptides by human angiotensin-converting enzyme-related carboxypeptidase. J Biol Chem 277: 14838-14843.
11. Soler MJ, Riera M, Crespo M, Mir M, Márquez E, et al. (2012) Circulating angiotensin converting enzyme (ACE)2 activity in kidney transplantation. A longitudinal pilot study. Nephron Clin Pract 121: c144-c150.
12. Huang L, Sexton DJ, Skogerson K, Devlin M, Smith R, et al. (2003) Novel peptide inhibitors of angiotensin-converting enzyme 2. J Biol Chem 278: 15532-15540.
13. Pitteri SJ, JeBailey L, Faca VM, Thorpe JD, Silva MA, et al. (2009) Integrated proteomic analysis of human cancer cells and plasma from tumor bearing mice for ovarian cancer biomarker discovery. PLoS One 4: e7916.
14. Ortiz-Perez JT, Meyers SN, Lee DC, Kansal P, Klocke FJ, et al. (2007) Angiographic estimates of myocardium at risk during acute myocardial infarction: validation study using cardiac magnetic resonance imaging. Eur Heart J 28: 1750-1758.
15. Amado LC, Gerber BL, Gupta SN, Rettmann DW, Szarf G, et al. (2004) Accurate and objective infarct sizing by contrast-enhanced magnetic resonance imaging in a canine myocardial infarction model. J Am Coll Cardiol 44: 2383-2389.
16. Hokimoto S, Yasue H, Fujimoto K, Yamamoto H, Nakao K, et al. (1996) Expression of angiotensin-converting enzyme in remaining viable myocytes of human ventricles after myocardial infarction. Circulation 94: 1513-1518.
17. Garabelli PJ, Modrall JG, Penninger JM, Ferrario CM, Chappell MC, (2008) Distinct roles for angiotensin-converting enzyme 2 and carboxypeptidase A in the processing of angiotensins within the murine heart. Exp Physiol 93: 613-621.
18. Kassiri Z, Zhong J, Guo D, Basu R, Wang X, et al. (2009) Loss of angiotensin-converting enzyme 2 accelerates maladaptive left ventricular remodeling in response to myocardial infarction. Circ Heart Fail 2: 446-455.
19. Der Sarkissian S, Grobe JL, Yuan L, Narielwala DR, Walter GA, et al. (2008) Cardiac overexpression of angiotensin converting enzyme 2 protects the heart from ischemia-induced pathophysiology. Hypertension 51: 712-718.
20. Soro-Paavonen A, Gordin D, Forsblom C, Rosengard-Barlund M, Waden J, et al. (2012) Circulating ACE2 activity is increased in patients with type 1 diabetes and vascular complications. J Hypertens 30: 375-383.
21. Zisman LS, Keller RS, Weaver B, Lin Q, Speth R, et al. (2003) Increased angiotensin-(1-7)-forming activity in failing human heart ventricles: evidence for upregulation of the angiotensin-converting enzyme Homologue ACE2. Circulation 108: 1707-1712.
22. Wang Y, Moreira Mda C, Heringer-Walther S, Ebermann L, Schultheiss HP, et al. (2010) Plasma ACE2 activity is an independent prognostic marker in Chagas' disease and equally potent as BNP. J Card Fail 16: 157-163.
23. Ocaranza MP, Godoy I, Jalil JE, Varas M, Collantes P, et al. (2006) Enalapril attenuates downregulation of Angiotensin-converting enzyme 2 in the late phase of ventricular dysfunction in myocardial infarcted rat. Hypertension 48: 572-578.